Health Canada — Medical Devices · Canada · 2018-05-11 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The Alaris Infusion Pump Administration Sets require priming prior to patient use as described in the directions for use. It is during the priming process that this issue can be observed. During priming, when attempting to fill the drip chamber, the drops into the drip chamber will not be observed once the roller clamp is opened. This issue is highly detectable.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.